Novafarma
Barcelona-based clinical telepharmacy company Novafarma, founded in 2021, operates a B2B2C platform and consulting practice delivering AI-enabled, value-based pharmaceutical care including teleconsultations, remote monitoring, and medication-therapy management for pharmaceutical laboratories, healthcare centers, insurers, and patient associations in Spain.
- Company typePrivate
- Founded2021
- HeadquartersBarcelona, Spain
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Novafarma does
Novafarma S.L. is a Barcelona-based clinical telepharmacy company founded in 2021 that operates a B2B2C platform delivering integrated pharmaceutical care to pharmaceutical laboratories, biotech firms, contract research organizations (CROs), healthcare centers (pharmacies, medical centers, nursing homes), health insurers, hospital networks, and patient associations, primarily in Spain. Its stated mission is to accelerate a "value-based digital pharmacy" model that integrates clinical pharmacy expertise with digital channels to improve pharmacotherapeutic outcomes, clinical safety, and patient well-being across the full care cycle.
Novafarma's offering is built on a core clinical telepharmacy platform (Plataforma de Telefarmacia Clínica) organized into three product modules: NovaCare (medication-related problem prevention and resolution via teleconsultation, remote patient monitoring, therapeutic reconciliation, and inter-professional consultation), NovaGov (design of value-based payment models and automated decision systems at care transitions), and NovaLab (patient-centered clinical trials incorporating social determinants of health, predictive machine-learning and deep-learning analytics, telepharmacy-enabled drug-launch support, and e-visit services). The platform combines AI, Big Data operational ("BigOps") techniques, and pharmacogenomics-based precision pharmacotherapy into a "unified therapeutic biography" that aggregates patient information across therapy sources. Disclosed operational metrics include 2,000+ pharmaceutical consultations attended, 600+ medication-related problems identified, and 1,000+ safety cases resolved involving interactions and contraindications.
Novafarma operates a sales-led, direct B2B go-to-market with two revenue streams: subscription/recurring licensing of the clinical telepharmacy platform (deployed for pharmaceutical industry, healthcare-center, and institutional clients) and professional-services revenue from digital transformation consulting for pharmacies and health systems migrating to value-based models. Pricing is not publicly disclosed and engagements are quote-based. The company is privately held, headquartered at G. Via de les Corts Catalanes 690, Barcelona, has a small team (1-10 employees), and lists co-founder Marta Lorca (CSO) alongside a co-founder with 20+ years of pharmaceutical industry experience.
Novafarma firmographics
Firmographics- Name
- Novafarma
- Legal name
- Novafarma S.L.
- Website
- https://novafarma.es
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Barcelona-based clinical telepharmacy company Novafarma, founded in 2021, operates a B2B2C platform and consulting practice delivering AI-enabled, value-based pharmaceutical care including teleconsultations, remote monitoring, and medication-therapy management for pharmaceutical laboratories, healthcare centers, insurers, and patient associations in Spain.
- Ownership category
- akta.pro rank
Novafarma industry classification
Industry- Product category
- Clinical Telepharmacy Services
- NAICS
- Other Ambulatory Health Care Services (6219), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
- akta.pro secondary industries
- Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
Keywords
Where Novafarma is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Novafarma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Clinical Telepharmacy Platform (B2B2C): Platform services for pharmaceutical laboratories, healthcare centers, and other institutions enabling integrated pharmaceutical care and patient monitoring.
- Digital Transformation Consulting (B2B): Advisory services for digital transformation of pharmacy towards integrated value-based care models, including change management and accompaniment plans.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Novafarma product offering
Product offeringCore offering
Novafarma provides B2B2C clinical telepharmacy services through its own Plataforma de Telefarmacia Clínica, which leverages AI and BigOps capabilities to deliver integrated pharmaceutical care. The company offers three specialized sub-brand products — novaLab (drug launch support and clinical trials), novaCare (programs for medication-related problems, lifestyle, and habits), and novaGov (payment models, public health, clinical management, and decision automation) — and also delivers B2B digital transformation consulting services.
Product overview
Novafarma is a value-based digital pharmacy company founded in 2021, offering a B2B2C clinical telepharmacy platform and digital transformation advisory services for the new integrated pharmacy model. The product portfolio consists of three named modules—NovaCare (medication problem prevention and resolution with AI), NovaGov (value-based payment models and decision automation), and NovaLab (patient-centered clinical trials with predictive AI)—delivered through a core clinical telepharmacy platform that enables pharmaceutical consultations, remote patient monitoring, teleconsultation, and professional inter-consultation orchestration across pharmaceutical industry, healthcare centers, and institutional clients in Spain.
Differentiator
Problem solved
Functional benefit
Brands
- novaLab: Solutions for pharmaceutical laboratories including clinical trials centered on patients through incorporation of social determinants of health (SDH), predictive solutions based on machine-deep learning and other AI techniques, launch of new drugs supported by telepharmacy accompaniment, e-Visit medical services, training for professionals in advanced therapies, and patient and healthcare worker training in the use of devices, apps, and wearables.
- novaCare
- novaGov
Products and services
- Plataforma de Telefarmacia Clínica Core proprietary digital platform that delivers B2B2C clinical telepharmacy services, leveraging AI and BigOps capabilities to provide integrated pharmaceutical care and a unified therapeutic biography (360° patient view). Targeted at the pharmaceutical industry, healthcare centers, and other institutions.
- novaLab Sub-brand product of Novafarma's telepharmacy platform focused on drug launch support and clinical trials for the pharmaceutical industry. Provides digital tools and clinical telepharmacy infrastructure to support pharmaceutical R&D and market entry activities.
- novaCare Sub-brand product of Novafarma's telepharmacy platform that provides programs addressing medication-related problems, lifestyle, and habits. Designed for healthcare centers and care delivery organizations to extend pharmaceutical care to patients beyond in-person visits.
- novaGov Sub-brand product of Novafarma's telepharmacy platform that addresses payment models, public health, clinical management, and decision automation. Designed for government agencies, public health authorities, and other public institutions managing pharmaceutical policy and reimbursement.
- Digital Transformation Consulting B2B consulting service from Novafarma supporting institutions in digital transformation, with a focus on the pharmaceutical and healthcare sectors. Offered in addition to the company's core telepharmacy platform.
Quantifiable outcome
- 2000+ pharmaceutical consultations attended
- +2 more outcomes
Companies that use Novafarma
Customer profileSegments3 records
Ideal customer profiles3 records
Novafarma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Novafarma partnerships and signals
Strategic signalScale indicators4 records
Recent moves3 records
Expansion highlights5 records
Novafarma competitors and assessment
Company assessmentMarket position
Strengths7 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Novafarma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novafarma leadership team
Management profileNumber of profiles
Profiles1 record
Novafarma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novafarma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novafarma
What does Novafarma do?
Novafarma provides B2B2C clinical telepharmacy services through its own Plataforma de Telefarmacia Clínica, which leverages AI and BigOps capabilities to deliver integrated pharmaceutical care. The company offers three specialized sub-brand products — novaLab (drug launch support and clinical trials), novaCare (programs for medication-related problems, lifestyle, and habits), and novaGov (payment models, public health, clinical management, and decision automation) — and also delivers B2B digital transformation consulting services.
Is Novafarma a public or private company?
Novafarma is a private company. It is classified as venture growth investor backed and is currently operating.
When was Novafarma founded?
Novafarma was founded in 2021. It employs 1 to 10 people.
Where is Novafarma based?
Novafarma is headquartered in Barcelona, Spain, in the Europe region.
How does Novafarma make money?
Two revenue lines are on record. Clinical Telepharmacy Platform (B2B2C) is the primary driver. The others are digital Transformation Consulting (B2B).
Does Novafarma have an API?
No public API is recorded for Novafarma.
What industry is Novafarma in?
Novafarma's product category is Clinical Telepharmacy Services. Its primary akta.pro industry code is HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM), with a secondary code of HLALACAK, Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored). Its NAICS code is 6219 and its SIC code is 8000.